Skip to main content
OpenTrials
Completed

NCT Number: NCT01696006

Perfusion CT Registry

The purpose of this study is to determine whether coronary perfusion computed tomography is effective in the treatment of coronary artery disease.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Asan Medical Center, Seoul, Songpa-Gu, South Korea

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age greater than or equal to 20
  • Patient who has a coronary perfusion computed tomography

Exclusion criteria

  • Unwillingness or inability to give informed consent

Treatment and study plan

Primary outcomes

  1. Accuracy of coronary perfusion computed tomography

    Time frame: 5year

    Positive predictive value Negative predictive value Sensitivity Specificity

Secondary outcomes

  1. Relationship between coronary perfusion computed tomography and fraction flow reserve

    Time frame: 5year

  2. Relationship between coronary perfusion computed tomography and SPECT(nuclear imaging)

    Time frame: 5year

  3. occurrence of the event after coronary perfusion computed tomography

    Time frame: 5year

    Death Myocardial infarction coronary angiography Revascularization

Sponsors and collaborators

Lead sponsor

Young-Hak Kim, MD, PhD

Other

Registry information

Acronym: Perfusion CT

Important dates

Study start
2013
Primary completion
2020
Study completion
2021
First posted
Sep 28, 2012
Registry last updated
Mar 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.